Longer time horizons and therapeutic area expertise make philanthropy venture capital an attractive option for biopharmaceutical companies developing new products. It can also de-risk funding rounds ...

Implementing AI in drug discovery offers significant potential for reducing operating costs, though the extent varies widely.

Job rotations provide an opportunity for promising, high-potential employees to grow and learn new parts of the business.

Using small molecule drugs to restore synapses in neurological diseases. Los Angeles-based Spinogenix, a privately held small molecule drug discovery and development company, is currently testing two ...